Copanlisib in Combination With Romidepsin in Patients With Relapsed or Refractory Mature T-cell Lymphoma
Condition: T-Cell Lymphoma Relapsed & Refractory Interventions: Drug: Copanlisib; Drug: Romidepsin Sponsors: Changchun Deng; Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials